The Perinatal Guidelines have been updated! For a complete preview of key updates to the guidelines, please see What's New in the Guidelines.
Please send your comments with the subject line “Comments on Perinatal Guidelines” to ContactUs@aidsinfo.nih.gov by April 11, 2014.
(Last updated:7/31/2012; last reviewed:7/31/2012)
Mother-to-child transmission has been observed across the entire range of plasma HIV RNA levels.1,2 HIV RNA levels correlate with risk of transmission even in women treated with antiretroviral (ARV) agents.3-5 Although the risk of perinatal transmission in women with undetectable HIV RNA levels appears to be extremely low, transmission has been reported even in women with very low or undetectable levels of maternal HIV RNA on antiretroviral therapy (ART).3-5 Additionally, although HIV RNA may be an important risk factor for transmission, other factors also appear to play a role.6-8
Although there is a general correlation between viral loads in plasma and in the genital tract, discordance between blood and genital tract virus has also been reported; low level cervico-vaginal HIV RNA and DNA shedding has been detected even in women treated with ART who have undetectable plasma viral load, particularly in the presence of genital tract coinfections.9-11 Penetration of ARV drugs into the female genital tract has been shown to vary between drugs.12-14 If exposure to HIV in the maternal genital tract during delivery is a risk factor for perinatal transmission, plasma HIV RNA levels may not always be an accurate indicator of risk. Long-term changes in one body compartment with ARV drugs may or may not be associated with comparable changes in other compartments. Additional studies are needed to determine the effect of ARV drugs on genital tract viral load and the association between such effects and the risk of perinatal transmission of HIV.
Because transmission can occur even when HIV RNA copy numbers are low or undetectable, all HIV-infected women should be counseled about and administered ARV drugs during pregnancy, regardless of their HIV RNA levels.